Vanioctamide : An alpha-adrenergic blocker with CGRP and NO releasing activities
碩士 === 高雄醫學大學 === 醫學研究所 === 89 === Abstract Vanioctamide (VOA), a vanilloid-based alpha-adrenoceptor antagonist, was designed and evaluated as a potential vasodilator with nitric oxide (NO) and calcitonin-gene related peptide (CGRP)-releasing activity. In in vivo studies, intra...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2001
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/97698457080447150209 |